Drugs targeting the renin?angiotensin?aldosterone system.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 621, doi. 10.1038/nrd873
- By:
- Publication type:
- Article
Works matching IS 14741776 AND DT 2002 AND VI 1 AND IP 8
Results: 21
1
2
CDKS and CKIS: Molecular targets for tissue remodelling.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 587, doi. 10.1038/nrd869
- By:
- Publication type:
- Article
3
Endogenous kynurenines as targets for drug discovery and development.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 609, doi. 10.1038/nrd870
- By:
- Publication type:
- Article
4
New tools and concepts for modern organic synthesis.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 573, doi. 10.1038/nrd871
- By:
- Publication type:
- Article
5
The use of constitutively active GPCRs in drug discovery and functional genomics.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 599, doi. 10.1038/nrd872
- By:
- Publication type:
- Article
6
The emergence of the drug receptor theory.
- Published in:
- 2002
- By:
- Publication type:
- journal article
7
Opinion: A proposal for FDA reform.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 642, doi. 10.1038/nrd874
- By:
- Publication type:
- Article
8
Timeline: The emergence of the drug receptor theory.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 637, doi. 10.1038/nrd875
- By:
- Publication type:
- Article
9
Sleep control: Regular as clockwork.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 565, doi. 10.1038/nrd876
- By:
- Publication type:
- Article
10
Lead identification: Best with both worlds?
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 570, doi. 10.1038/nrd877
- By:
- Publication type:
- Article
11
Anticancer drugs: Next in line?
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 566, doi. 10.1038/nrd878
- By:
- Publication type:
- Article
12
Heat-shock proteins: TNF in hot shocker.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 568, doi. 10.1038/nrd879
- By:
- Publication type:
- Article
13
Viral infections: Exchange control.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 567, doi. 10.1038/nrd880
- By:
- Publication type:
- Article
14
Anticancer drugs: Deadly cargo.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 568, doi. 10.1038/nrd881
- By:
- Publication type:
- Article
15
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 569, doi. 10.1038/nrd882
- Publication type:
- Article
16
Patent Watch.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 570
- Publication type:
- Article
17
From the analyst's couch: Value of novelty?
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 571, doi. 10.1038/nrd884
- By:
- Publication type:
- Article
18
Adrenoceptor pharmacology: How the ligand changed its spots.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 569, doi. 10.1038/nrd885
- By:
- Publication type:
- Article
19
Mass spectrometry in drug discovery and development.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 651, doi. 10.1038/nrd886
- By:
- Publication type:
- Article
20
Stress-related disorders: Controlling emotion.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 8, p. 566, doi. 10.1038/nrd887
- By:
- Publication type:
- Article
21
New resources on the horizon.
- Published in:
- 2002
- Publication type:
- Editorial